1. Home
  2. LYRA vs SAIH Comparison

LYRA vs SAIH Comparison

Compare LYRA & SAIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • SAIH
  • Stock Information
  • Founded
  • LYRA 2005
  • SAIH 2019
  • Country
  • LYRA United States
  • SAIH Singapore
  • Employees
  • LYRA N/A
  • SAIH N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • SAIH
  • Sector
  • LYRA Health Care
  • SAIH
  • Exchange
  • LYRA Nasdaq
  • SAIH NYSE
  • Market Cap
  • LYRA 15.0M
  • SAIH 12.3M
  • IPO Year
  • LYRA 2020
  • SAIH N/A
  • Fundamental
  • Price
  • LYRA $9.40
  • SAIH $7.20
  • Analyst Decision
  • LYRA Buy
  • SAIH
  • Analyst Count
  • LYRA 2
  • SAIH 0
  • Target Price
  • LYRA $16.00
  • SAIH N/A
  • AVG Volume (30 Days)
  • LYRA 1.9M
  • SAIH 20.2K
  • Earning Date
  • LYRA 08-13-2025
  • SAIH 04-28-2025
  • Dividend Yield
  • LYRA N/A
  • SAIH N/A
  • EPS Growth
  • LYRA N/A
  • SAIH N/A
  • EPS
  • LYRA N/A
  • SAIH N/A
  • Revenue
  • LYRA $1,185,000.00
  • SAIH $5,543,000.00
  • Revenue This Year
  • LYRA N/A
  • SAIH N/A
  • Revenue Next Year
  • LYRA $1,286.17
  • SAIH N/A
  • P/E Ratio
  • LYRA N/A
  • SAIH N/A
  • Revenue Growth
  • LYRA N/A
  • SAIH N/A
  • 52 Week Low
  • LYRA $3.81
  • SAIH $3.00
  • 52 Week High
  • LYRA $37.50
  • SAIH $26.98
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 45.31
  • SAIH N/A
  • Support Level
  • LYRA $10.15
  • SAIH N/A
  • Resistance Level
  • LYRA $14.88
  • SAIH N/A
  • Average True Range (ATR)
  • LYRA 2.03
  • SAIH 0.00
  • MACD
  • LYRA -0.67
  • SAIH 0.00
  • Stochastic Oscillator
  • LYRA 0.42
  • SAIH 0.00

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About SAIH SAIHEAT LIMITED

Saiheat Ltd develops technologies for the Computing Center Ecosystem (ACCE), a next-gen computing center featuring high-performance servers, liquid cooling, and systems for capturing and recycling computing heat. It aims to reduce the carbon footprint of Bitcoin mining and AI operations. The Company has four reportable segments: equipment sales, hosting, mining pool business, and mining.

Share on Social Networks: